FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1324-1325 May 1, 1997 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Roldan, C. A.

To the Editor: The article by Roldan et al. on valvular heart disease associated with systemic lupus erythematosus (Nov. 7 issue)¹ prompts two remarks. First, the authors did not give any data on antiphospholipid antibodies. There are at least five studies showing an association between the presence of antiphospholipid antibodies and valvular heart disease in patients with lupus.² Furthermore, antiphospholipid antibodies have been detected in heart-valve lesions, suggesting a causative role of these antibodies.³ The close association of antiphospholipid antibodies with thrombotic events has shed light on the focal neurologic manifestations of lupus. Indeed, these manifestations, previously assumed to result . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bijl, M, Brouwer, J, Kallenberg, G G. (2000). Grand Rounds from International Lupus Centres Cardiac abnormalities in SLE: pancarditis. Lupus 9: 236-240 [Abstract]